ACH
Accendra Health Inc
0.708$
-3.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41.6% | 41.3% | 42.9% | 43.9% | 41.7% | 43.4% | 45.4% | 55.3% | 52.8% | 22.3% | 24.4% | 12.9% | |
| 4.2% | 4.8% | 4.7% | 4.8% | 0.9% | 1.1% | 1.2% | 0.9% | 0.8% | 11.5% | 13.9% | 0.4% | |
| 4.2% | 4.8% | 4.7% | 4.8% | 0.9% | 1.1% | 1.2% | 0.9% | 0.8% | 11.5% | 13.9% | 0.4% | |
| 13.3% | 11.7% | 12.9% | 12.5% | 13.0% | 14.8% | 11.9% | 4.7% | 5.0% | 3.9% | 4.3% | 5.7% | |
| 21.2% | 21.8% | 22.0% | 23.2% | 24.5% | 24.3% | 29.0% | 1.7% | 1.6% | 3.0% | 2.7% | 3.5% | |
| – | – | – | – | – | – | 18.6% | 9.1% | 9.4% | 14.9% | – | – | |
| 31.9% | 32.2% | 31.4% | 30.8% | 32.3% | 28.6% | 27.4% | 29.6% | 30.4% | 50.1% | 50.8% | 58.3% | |
| 7.4% | 7.1% | 6.6% | 6.1% | 6.2% | 6.4% | 5.8% | 4.7% | 4.1% | 5.6% | 4.4% | 3.7% | |
| 82.7% | 81.9% | 82.8% | 83.8% | 82.8% | 87.9% | 88.2% | 106.8% | 110.6% | 118.8% | 119.2% | 126.1% | |
| 33.8% | 37.1% | 37.1% | 40.2% | 38.1% | 40.2% | 40.4% | 64.4% | 61.1% | 38.6% | 49.8% | 31.6% | |
| 2.3% | 5.7% | 4.2% | 4.1% | 0.9% | 1.1% | 1.0% | 10.3% | 6.9% | 12.0% | 24.1% | – | |
| 23.1% | 23.0% | 23.4% | 26.1% | 26.3% | 26.9% | 28.4% | 8.6% | 8.4% | 14.8% | 15.5% | 16.7% | |
| – | – | – | – | 36.3% | 38.6% | 38.9% | 38.4% | 45.5% | 73.4% | 63.0% | 81.5% | |
| 17.3% | 18.1% | 17.2% | 16.2% | 17.2% | 12.1% | 11.8% | -6.8% | -10.6% | -18.8% | -19.2% | -26.1% | |
| 6.8% | 7.2% | 6.7% | 5.9% | 5.9% | 0.1% | 0.0% | -21.0% | -25.3% | -44.0% | -45.0% | -55.8% | |
| 1.5% | 1.5% | 1.5% | 1.4% | 1.5% | 1.7% | 1.6% | 1.9% | 1.9% | 3.1% | 3.2% | 3.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.